Methods ablating tissue using a catheter-based injection system
US-9131983-B2 · Sep 15, 2015 · US
US11964113B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11964113-B2 |
| Application number | US-202117232662-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 16, 2021 |
| Priority date | Apr 22, 2011 |
| Publication date | Apr 23, 2024 |
| Grant date | Apr 23, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
At the present time, physicians often treat patients with atrial fibrillation (AF) using radiofrequency (RF) catheter systems to ablate conducting tissue in the wall of the Left Atrium of the heart around the ostium of the pulmonary veins. These systems are expensive and take time consuming to use. The present invention circular ablation system CAS includes a multiplicity of expandable needles that can be expanded around a central axis and positioned to inject a fluid like ethanol to ablate conductive tissue in a ring around the ostium of a pulmonary vein quickly and without the need for expensive capital equipment. The expansion of the needles is accomplished by self-expanding or balloon expandable structures. The invention includes centering means so that the needles will be situated in a pattern surrounding the outside of the ostium of a vein. Also included are members that limit the distance of penetration of the needles into the wall of the left atrium, or the aortic wall. The present invention also has an important application to ablate tissue around the ostium of one or both renal arteries, for the ablation of the sympathetic nerve fibers and/or other afferent or efferent nerves going to or from each kidney in order to treat hypertension.
Opening claim text (preview).
What is claimed is: 1. An ablation system comprising: a catheter body; an uniform expansion structure comprising at least two tubular structures, each tubular structure comprising a proximal end and a distal end, the distal ends of the least two tubular structures configured to rest against tissue, wherein the uniform expansion structure comprises a coupling member, wherein the coupling member is directly attached to the proximal ends of the at least two tubular structures, wherein the coupling member is configured to allow simultaneous and circumferential deployment of the at least two tubular structures; at least two injectors comprising an injector tube and an injector needle, each injector comprising a proximal end and a distal end, a portion near the distal end of each injector configured coaxially within a corresponding tubular structure, the distal end of each injector configured to penetrate tissue; and an injector manifold directly attached to the proximal ends of the at least two injectors, wherein the uniform expansion structure and the injector manifold are separate components, wherein each injector is configured to penetrate the same pre-set distance into tissue in the deployed configuration while the distal ends of the tubular structures rest against tissue. 2. The ablation system of claim 1 , wherein the at least two injectors are configured to inject an ablative fluid. 3. The ablation system of claim 1 , wherein the spacing between the at least two tubular structures is uniform. 4. The ablation system of claim 1 , further comprising a guide wire. 5. The ablation system of claim 4 , wherein the catheter body is configured to advance over the guide wire. 6. The ablation system of claim 4 , wherein the coupling member is configured to advance over the guide wire. 7. The ablation system of claim 1 , wherein the at least two injectors comprise a shape memory material. 8. The ablation system of claim 1 , further comprising a radiopaque marker configured to mark the position of an injector of the at least two injectors. 9. The ablation system of claim 1 , further comprising a radiopaque marker configured to mark the position a tubular structures of the at least two tubular structures. 10. The ablation system of claim 1 , wherein each tubular structure of the at least two tubular structures comprises a flattened distal end. 11. An ablation system comprising: a catheter body; an uniform expansion structure comprising at least two tubular structures, each tubular structure comprising a proximal end and a distal end, the distal ends of the least two tubular structures configured to rest against tissue, wherein the uniform expansion structure comprises a stabilizing structure, wherein the stabilizing structure is directly attached to the proximal ends of the at least two tubular structures, wherein the stabilizing structure controls the expansion of the at least two tubular structures; at least two injectors, each injector comprising a proximal end and a distal end, a portion near the distal end of each injector configured coaxially within a corresponding tubular structure, the distal end of each injector configured to penetrate tissue; and an injector manifold directly attached to the proximal ends of the at least two injectors, wherein the at least two injectors have a pre-set maximum injector diameter, wherein the at least two tubular structures have a pre-set maximum tubular structure diameter, wherein the at least two injectors are configured to penetrate the same pre-set distance into tissue while the distal ends of the tubular structures rest against tissue. 12. The ablation system of claim 11 , wherein the at least two injectors are configured to inject an ablative fluid. 13. The ablation system of claim 11 , wherein the at least two injectors comprise a shape memory material. 14. The ablation system of claim 11 , wherein a tubular structure of the at least two tubular structures comprise a radiopaque material. 15. The ablation system of claim 11 , wherein an injector of the at least two injectors comprise a radiopaque material. 16. The ablation system of claim 11 , further comprising a radiopaque marker. 17. The ablation system of claim 11 , wherein each injector is configured to inject an ablative fluid. 18. The ablation system of claim 11 , wherein the spacing between the plurality of tubular structures is uniform.
being one or more injection needles · CPC title
Invasive · CPC title
having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence) · CPC title
Markers, e.g. radio-opaque or breast lesions markers · CPC title
with a guide wire · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.